Piu Medical SpA (FRA:IV3) Revenue: € Mil (TTM As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:IV3 Piu Medical SpA FRA:IV3
14 GF Score
Price €5.45
! 5 Warning Signs
View Full Analysis

What is Piu Medical SpA Revenue?

Piu Medical SpA FRA:IV3 -2.68% 14 Revenue is € Mil as of Jun. 2025. GuruFocus rates FRA:IV3 with a GF Score™ of 14/100. The stock has 5 warning signs investors should review.

Piu Medical SpA's revenue for the six months ended in Jun. 2025 was €13.36 Mil. Piu Medical SpA does not have enough years/quarters to calculate its revenue for the trailing twelve months (TTM) ended in Jun. 2025. Piu Medical SpA's Revenue per Share for the six months ended in Jun. 2025 was €2.10. Piu Medical SpA does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2025.

During the past 12 months, the average Revenue per Share Growth Rate of Piu Medical SpA was -74.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

Piu Medical SpA  (FRA:IV3) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Piu Medical SpA Revenue Related Terms

Piu Medical SpA Revenue Historical Data

* Premium members only.

The historical data trend for Piu Medical SpA's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Piu Medical SpA Revenue Chart

Piu Medical SpA Annual Data
Trend Dec23 Dec24 Dec25
Revenue
25.09 26.08 6.62

Piu Medical SpA Semi-Annual Data
Dec23 Dec24 Jun25 Dec25
Revenue 0.00 0.00 13.36 -6.74

Piu Medical SpA Revenue Competitor Comparison

For the Pharmaceutical Retailers subindustry, Piu Medical SpA's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Piu Medical SpA Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Piu Medical SpA's Revenue distribution charts can be found below:

* The bar in red indicates where Piu Medical SpA's Revenue falls into.


FRA:IV3
14GF Score
Piu Medical SpA FRA:IV3
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Piu Medical SpA Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of € Mil mean?
Piu Medical SpA (FRA:IV3) has a Revenue of € Mil as of Jun. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Piu Medical SpA and its competitors.
Is Piu Medical SpA's Revenue too high?
Piu Medical SpA's current Revenue is € Mil. Overall, Piu Medical SpA has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Piu Medical SpA's Revenue compare to competitors?
Piu Medical SpA's Revenue of € Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Piu Medical SpA and its competitors. Piu Medical SpA's current Revenue is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Piu Medical SpA stock overvalued right now?
Piu Medical SpA (FRA:IV3) has a current Revenue of € Mil. The current Revenue is € Mil. Piu Medical SpA's overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Piu Medical SpA (FRA:IV3), the current Revenue is € Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Piu Medical SpA Business Description

Other Exchanges PMED:Italy
Address Viale LombardiA 62, Castronno, ITA, IT-21040
Piu Medical SpA specializes in the retail distribution of pharmaceutical and parapharmaceutical products. Its activity includes: sale of prescription drugs; sale of OTC and parapharmaceutical products: OTC medicines, dietary supplements, medical devices, paramedical products, personal care and wellness products, homeopathic medicines, cosmetics, etc.; services: diagnostic testing services, blood parameter analysis and control (glycemia, cholesterol, triglycerides, etc.), rapid testing and screening, nutritional consultation, remote medical assistance and monitoring, telemedicine, etc.
14GF Score

Get the complete analysis for FRA:IV3

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.45
Price